Keiichi Matsubara
Overview
Explore the profile of Keiichi Matsubara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
397
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yoshino Y, Yagi T, Tsubouchi K, Takaishi Y, Ozaki Y, Iga J, et al.
Neuropsychopharmacol Rep
. 2025 Jan;
45(1):e70005.
PMID: 39887672
Background: Maternal psychiatric condition during the perinatal period is relevant to children's cognitive development and mental health. Psychotropic medications are necessary to maintain the mental health of pregnant women with...
2.
Jwa S, Takano N, Tamaru S, Kijima S, Uesato T, Matsubara K, et al.
Hypertens Res
. 2024 Oct;
48(1):110-120.
PMID: 39443705
This multicenter prospective study investigated seasonal variation in home blood pressure (HBP) during pregnancy and its association with the frequency of hypertensive disorders of pregnancy (HDP) and developed trimester-specific upper...
3.
Matsubara K, Matsubara Y, Uchikura Y, Sugiyama T
Curr Issues Mol Biol
. 2024 Sep;
46(9):9760-9771.
PMID: 39329931
Angiotensin II (AngII) receptor subtype 1 (AT1R) is involved in the pathogenesis of preeclampsia (PE). Angiotensin II receptor subtype 2 (AT2R) can antagonize the effects of AT1R, but its effects...
4.
Kubo A, Matsubara K, Matsubara Y, Nakaoka H, Sugiyama T
Int J Mol Sci
. 2023 Jul;
24(13).
PMID: 37446304
Preeclampsia (PE) is a serious complication of pregnancy with a pathogenesis that is not fully understood, though it involves the impaired invasion of extravillous trophoblasts (EVTs) into the decidual layer...
5.
Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T, et al.
J Reprod Immunol
. 2023 Jun;
158:103977.
PMID: 37354783
The aim was to evaluate whether natural killer (NK) cells and regulatory T (Treg) cells were involved in mechanisms underlying beneficial effects of a high dose of intravenous immunoglobulin (IVIG)...
6.
Kaneko K, Tsutsumi S, Fujita D, Sugiura-Ogasawara M, Mitsuda N, Matsubara K, et al.
Mod Rheumatol
. 2023 Jun;
34(3):515-522.
PMID: 37340865
Objectives: The objective of the study was to compare the efficacy of intravenous immunoglobulin (IVIG) therapy for obstetric antiphospholipid syndrome (APS) refractory to conventional treatment. Methods: We conducted a single-arm,...
7.
Ohkuchi A, Suzuki H, Matsubara K, Watanabe K, Saitou T, Oda H, et al.
Hypertens Res
. 2022 Sep;
45(11):1679-1689.
PMID: 36109601
According to the 2004 Japanese definition, early-onset (EO) preeclampsia (PE) is defined as PE occurring at <32 weeks of gestation. This was based on the presence of "dual peaks" (30-31...
8.
Suzuki Y, Matsubara K, Watanabe K, Tanaka K, Yamamoto T, Nohira T, et al.
Hypertens Res
. 2022 Aug;
45(10):1563-1574.
PMID: 35974173
In the near future, hypertensive disorders of pregnancy (HDP) have been diagnosed by home blood pressure monitoring (HBPM) instead of clinic BP monitoring. A multicenter study of HBPM was performed...
9.
Yamada H, Deguchi M, Saito S, Takeshita T, Mitsui M, Saito T, et al.
EClinicalMedicine
. 2022 Jul;
50:101527.
PMID: 35795714
Background: There is no effective treatment for women with unexplained recurrent pregnancy loss (RPL). We aimed to investigate whether treatment with a high dose of intravenous immunoglobulin (IVIG) in early...
10.
Konishi A, Samura O, Muromoto J, Okamoto Y, Takahashi H, Kasai Y, et al.
J Hum Genet
. 2022 Jan;
67(5):261-265.
PMID: 34974528
The incidence of chromosomal abnormalities in twin pregnancies is not well-studied. In this retrospective study, we investigated the frequency of chromosomal abnormalities in twin pregnancies and compared the incidence of...